The global landscape of biopharmaceuticals is currently being reshaped by the rapid evolution of targeted therapies and precision diagnostics. According to the latest Antibodies Market Trends, the industry is entering a "Golden Age of Engineering," characterized by the transition from simple monoclonal antibodies (mAbs) to multi-specific and modular formats. In 2025, the market is witnessing a...
English
Kurmanji
Arabic
French
فِارسي
Turkish
Dutch
Russian
Greek